Arcus Biosciences RCUS Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcus Biosciences's interest expense?
- Arcus Biosciences (RCUS) reported interest expense of $3M in Q1 2026.
- How has Arcus Biosciences's interest expense changed year-over-year?
- Arcus Biosciences's interest expense increased by 200.0% year-over-year, from $1M to $3M.
- What is the long-term trend for Arcus Biosciences's interest expense?
- Over 2 years (2022 to 2025), Arcus Biosciences's interest expense has grown at a 100.0% compound annual growth rate (CAGR), from $2M to $8M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.